Shelf-life estimation for multifactor stability studies

Drug Information Journal

Volumn 31, Issue 2, 1997, Pages 573-587

  Chen, James J ^a   Ahn, Hongshik ^a   Tsong, Yi ^b  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Analysis of covariance; Batch; Expiration dating period; Package; Strength

Indexed keywords

CONFERENCE PAPER; DRUG PACKAGING; EXPIRATION DATE; FOOD AND DRUG ADMINISTRATION; PRIORITY JOURNAL; SHELF LIFE; STATISTICAL ANALYSIS; SYSTEM ANALYSIS;

EID: 0030908199     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159703100225     Document Type: Conference Paper

References (18)

1. Food and Drug Administration. Guideline for Submitting Documentation for the Stability of Human Drugs and Biologics. U.S. Department of Health and Human Services: Rockville, Maryland; 1987.
2. Federal Register. International Conference on Harmonization: Stability Testing of New Drugs Substances and Products; Guideline; Availability; Notice. 1994;48754-48759.
3. Fairweather WR, Lin TD, Roswitha K. Regulatory, design, analysis aspects of complex stability studies. J Pharma Sci. 1995;84:1322-1326.
4. Lin KK, Lin TD, Roswitha K. Stability of drugs. In Statistics in the Pharmaceutical Industry. 2nd edition. Buncher CR, Tsay JY eds. New York: Marcel Dekker; 1993;419-444.
5. Bancroft TA. Analysis and inference for incompletely specified models involving the use of preliminary test(s) of significance. Biometrics. 1964;20:427-442.
6. Lin TD, Tsong Y. Determination of significance level for pooling data in stability studies. American Statistical Association 1991 Proceedings of the Biopharmaceutical Section. 1991;195-201.
7. Chow SC, Liu JP. Statistical Design and Analysis in Pharmaceutical Sciences. New York: Marcel Dekker; 1995.
8. Ahn H, Chen JJ, Lin TD. Classification of batches in a stability study. American Statistical Association 1995 Proceedings of the Biopharmaceutical Section. 1995.
9. Lin TD. Applicability of matrix and bracket approach to stability study design. American Statistical Association 1994 Proceedings of the Biopharmaceutical Section. 1994;142-147.
10. Shao J, Chow SC. Statistical inference in stability analysis. Biometrics. 1994;50:753-763.
11. Ruberg SJ, Stegeman JW. Pooling data for stability studies: Testing the equality of batch degradation slopes. Biometrics. 1991;47:1059-1069.
12. Ruberg SJ, Hsu JC. Multiple comparison procedures for pooling batches in stability studies. Technometrics. 1992;34:465-472.
13. Chow SC, Shao J. Estimating drug shelf-life with random batches. Biometrics. 1991;47:1071-1079.
14. Murphy JR, Weisman D. Using random slopes for estimating shelf-life. American Statistical Association 1990 Proceedings of the Biopharmaceutical Section. 1990;196-200.
15. Chen JJ, Hwang JS, Tsong Y. Estimation of the shelf-life of drugs with mixed effects models. J Biopharma Stat. 1995;5:131-140.
16. Ho CH, Liu JP, Chow SC. On the analysis of stability data. American Statistical Association 1992 Proceedings of the Biopharmaceutical Section. 1992;198-203.
17. Chow SC, Liu JP. Design and Analysis of Bioavailability and Bioequivalence Studies. New York: Marcel Dekker; 1992.
18. Nordbrock E. Statistical comparison of stability study designs. J Biopharma Stat. 1992;2:91-113.